Literature DB >> 22454839

Ligand binding assays in the 21st Century laboratory: platforms.

Franklin P Spriggs1, Zhandong Don Zhong, Afshin Safavi, Darshana Jani, Narasaiah Dontha, Anita Kant, Jenny Ly, Lia Brilando, Karolina Österlund, Nathalie Rouleau, Saloumeh Kadkhodayan Fischer, Martin Boissonneault, Chad Ray.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22454839      PMCID： PMC3291195          DOI： 10.1208/s12248-012-9321-1

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  20 in total

1.  Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.

Authors:  Xiang Wu; J Fraser Glickman; Benjamin R Bowen; Matthew A Sills
Journal:  J Biomol Screen       Date:  2003-08

2.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

3.  Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.

Authors:  Alvydas Mikulskis; Dave Yeung; Meena Subramanyam; Lakshmi Amaravadi
Journal:  J Immunol Methods       Date:  2010-12-01       Impact factor: 2.303

4.  Ligand-binding assays: risk of using a platform supported by a single vendor.

Authors:  Jennifer Yohrling
Journal:  Bioanalysis       Date:  2009-06       Impact factor: 2.681

5.  An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen.

Authors:  Aaron Patton; Michael C Mullenix; Steven J Swanson; Eugen Koren
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

6.  Fit-for-purpose method development and validation for successful biomarker measurement.

Authors:  Jean W Lee; Viswanath Devanarayan; Yu Chen Barrett; Russell Weiner; John Allinson; Scott Fountain; Stephen Keller; Ira Weinryb; Marie Green; Larry Duan; James A Rogers; Robert Millham; Peter J O'Brien; Jeff Sailstad; Masood Khan; Chad Ray; John A Wagner
Journal:  Pharm Res       Date:  2006-01-12       Impact factor: 4.200

Review 7.  Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.

Authors:  Gopi Shankar; Viswanath Devanarayan; Lakshmi Amaravadi; Yu Chen Barrett; Ronald Bowsher; Deborah Finco-Kent; Michele Fiscella; Boris Gorovits; Susan Kirschner; Michael Moxness; Thomas Parish; Valerie Quarmby; Holly Smith; Wendell Smith; Linda A Zuckerman; Eugen Koren
Journal:  J Pharm Biomed Anal       Date:  2008-09-19       Impact factor: 3.935

8.  Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method.

Authors:  E F Ullman; H Kirakossian; A C Switchenko; J Ishkanian; M Ericson; C A Wartchow; M Pirio; J Pease; B R Irvin; S Singh; R Singh; R Patel; A Dafforn; D Davalian; C Skold; N Kurn; D B Wagner
Journal:  Clin Chem       Date:  1996-09       Impact factor: 8.327

9.  Comparison of the NIDS® rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics.

Authors:  Jing Pan; Thomas Small; Dujie Qin; Shawn Li; Li Wang; Dave Chen; Cindy Pauley; Thorsten Verch; Catherine Kaplanski; Ray Bakhtiar; Yli Remo Vallejo; Ray Yin
Journal:  J Pharmacol Toxicol Methods       Date:  2010-09-22       Impact factor: 1.950

10.  Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab.

Authors:  James A Lofgren; Sripriya Dhandapani; Jason J Pennucci; Christina M Abbott; Daniel T Mytych; Arunan Kaliyaperumal; Steven J Swanson; Michael C Mullenix
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422
View more
  2 in total

1.  Ligand binding assays in the 21st century laboratory-a call for change.

Authors:  Chad A Ray; Ago B Ahene
Journal:  AAPS J       Date:  2012-04-03       Impact factor: 4.009

Review 2.  A white paper--consensus and recommendations of a global harmonization team on assessing the impact of immunogenicity on pharmacokinetic measurements.

Authors:  J M Sailstad; L Amaravadi; A Clements-Egan; B Gorovits; H A Myler; R C Pillutla; S Pursuhothama; M Putman; M K Rose; K Sonehara; L Tang; J T Wustner
Journal:  AAPS J       Date:  2014-03-29       Impact factor: 4.009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.